Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a pharmaceutical company that develops, manufactures, and sells generic and proprietary injectable and inhalation drug products. The company generates revenue through transactional sales of finished pharmaceutical products to healthcare customers. The filing excerpts available from the 10-K filed 2026-02-26 (accession 000129718426000009) do not provide sufficient detail to characterize segment revenue breakdown, market position, key competitors, geographic mix, customer concentration, capital structure, or founding and leadership history with the specificity required for accurate attribution. Only the company name, ticker, and exchange on the Nasdaq Global Select Market are directly supported by the filing excerpts provided.

Revenue model

The filing excerpts do not provide sufficient detail to describe the revenue model with supported specifics.

Products and services

The filing excerpts do not provide sufficient product or brand detail to list specific products with accuracy.

Customers and end markets

The filing excerpts do not provide sufficient customer or end-market detail to characterize with accuracy.

Value-chain role

The filing excerpts do not provide sufficient detail to characterize the value-chain role with accuracy.

Geographic exposure

The filing excerpts do not provide sufficient geographic detail to characterize exposure with accuracy.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: Amylyx Pharmaceuticals Inc CinCor Pharma, Inc. Johnson & Johnson NGM BIOPHARMACEUTICALS INC Pliant Therapeutics Inc Supernus Pharmaceuticals Inc Tilray Brands Inc